[HTML][HTML] The role of emotions in cancer patients' decision-making
K Mazzocco, M Masiero, MC Carriero… - …, 2019 - ncbi.nlm.nih.gov
Objective The objective of the present review is to provide a brief overview of research on
decision making and cancer with a specific focus on the role of emotions. Method Thirty-nine …
decision making and cancer with a specific focus on the role of emotions. Method Thirty-nine …
[HTML][HTML] Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Polygenic factors are estimated to account for an additional 18% of the familial relative risk
of breast cancer, with those at the highest level of polygenic risk distribution having a least a …
of breast cancer, with those at the highest level of polygenic risk distribution having a least a …
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
D Cragun, A Weidner, C Lewis, D Bonner, J Kim… - Cancer, 2017 - Wiley Online Library
BACKGROUND Breast cancer (BC) disparities may widen with genomic advances. The
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up
Purpose The ongoing integration of cancer genomic testing into routine clinical care has led
to increased demand for cancer genetic services. To meet this demand, there is an urgent …
to increased demand for cancer genetic services. To meet this demand, there is an urgent …
[HTML][HTML] Decision making for breast cancer prevention among women at elevated risk
Several medical management approaches have been shown to be effective in preventing
breast cancer and detecting it early among women at elevated risk: 1) prophylactic …
breast cancer and detecting it early among women at elevated risk: 1) prophylactic …
Risk management options elected by women after testing positive for a BRCA mutation
C Garcia, J Wendt, L Lyon, J Jones, RD Littell… - Gynecologic …, 2014 - Elsevier
Objective To assess the uptake of risk-reducing options for the management of ovarian and
breast cancer risk in BRCA mutation carriers in a large community based integrated health …
breast cancer risk in BRCA mutation carriers in a large community based integrated health …
Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress
Studies suggest that patients carrying a BRCA variant of uncertain significance (VUS) may
have lingering confusion concerning results interpretation. Counseling for uninformative …
have lingering confusion concerning results interpretation. Counseling for uninformative …
Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities
KF Mittendorf, S Knerr, TL Kauffman… - JCO Precision …, 2021 - ascopubs.org
Hereditary cancer syndromes result from germline genetic alterations predisposing
individuals to higher lifetime cancer risk than the general population. Hereditary cancer …
individuals to higher lifetime cancer risk than the general population. Hereditary cancer …
A role for common genomic variants in the assessment of familial breast cancer
S Sawyer, G Mitchell, J McKinley… - Journal of clinical …, 2012 - ascopubs.org
Purpose Genome-wide association studies have identified common genomic variants
associated with increased susceptibility to breast cancer. In the general population, the risk …
associated with increased susceptibility to breast cancer. In the general population, the risk …
[HTML][HTML] Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing
U Francke, C Dijamco, AK Kiefer, N Eriksson, B Moiseff… - PeerJ, 2013 - peerj.com
Background. Inherited BRCA gene mutations convey a high risk for breast and ovarian
cancer, but current guidelines limit BRCA mutation testing to women with early-onset cancer …
cancer, but current guidelines limit BRCA mutation testing to women with early-onset cancer …